CAAS Capital Management’s Crinetics Pharmaceuticals CRNX Stock Holding History

CAAS Capital Management’s Portfolio CRNX Stock Details CRNX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell
2021 Q2	$3.13M	Buy
2020 Q4	–	Sell
2020 Q3	$561K	Sell
2020 Q2	$2.06M	Buy